{{Rsnum
|rsid=4986909
|Orientation=plus
|ReferenceAllele=C
|MissenseAllele=T
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Chromosome=7
|position=99762047
|Gene=CYP3A4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=CYP3A4
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 99.1 | 0.9 | 0.0
| HCB | 98.5 | 1.5 | 0.0
| JPT | 99.1 | 0.9 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 98.5 | 1.5 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 96.6 | 3.4 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}[[rs4986909]], also known as 1247C>T, 22026C>T or P416L, is a SNP in the [[CYP3A4]] gene.

The [[rs4986909]](T) allele defines the CYP3A4*13 variant.

{{PharmGKB
|RSID=rs4986909
|Name_s=CYP3A4:P416L; CYP3A4:1351 C>T; CYP3A4:416 Pro>Leu; CYP3A4*13
|Gene_s=CYP3A4, CYP3A, CYP3A5P2
|Feature=Exon, NA, NA
|Evidence=Web Resource:http://www.pharmgkb.org/search/annotatedGene/cyp3a4/haplotype.jsp#ImportantHaplotypeInformationforCYP3A4-31
|Annotation=Defining variant for CYP3A4*13; in vitro, this allele did not result in detectable P450 holoprotein.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=In-Depth
|PharmGKB Accession ID=PA161145178
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}